Can Ozempic (semaglutide) be used long-term and what are its long-term effects?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Long-term Use of Ozempic (Semaglutide): Effects and Considerations

Ozempic (semaglutide) can be used long-term for appropriate patients, but requires ongoing monitoring for potential side effects including gastrointestinal issues, pancreatitis, retinopathy complications, and gallbladder disease. While clinical trials support its continued use for diabetes management and cardiovascular risk reduction, there is limited data beyond 5 years of continuous use.

Long-term Benefits of Ozempic

Ozempic provides several important long-term benefits:

  • Sustained glycemic control: Effective for long-term management of type 2 diabetes 1
  • Weight reduction: Significant and sustained weight loss of 3.47-6.5 kg on average 2, 1
  • Cardiovascular protection: Reduces major adverse cardiovascular events by 13-26% in patients with established cardiovascular disease 2, 3
  • Renal protection: May improve kidney function parameters including reducing albuminuria 4

Long-term Side Effects and Risks

Gastrointestinal Effects

  • Common side effects: Nausea, vomiting, diarrhea (most common adverse effects) 5, 1
  • Incidence: Affects up to 38% of patients but typically diminishes over time 5
  • Management: Gradual dose titration, smaller meals, avoiding high-fat foods 5

Serious Potential Complications

  • Pancreatitis: Incidence of 0.3 cases per 100 patient-years; requires immediate discontinuation if suspected 6
  • Diabetic retinopathy complications: Higher risk in patients with pre-existing retinopathy (8.2% vs 5.2% with placebo) 6
  • Thyroid C-cell tumors: Contraindicated in patients with personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia type 2 6
  • Gallbladder disease: Increased risk with long-term use 2
  • Acute kidney injury: Rare cases reported, particularly with dehydration from GI side effects 6

Psychiatric Effects

  • Depression: Case reports suggest potential association with depression in some patients 7

Monitoring Requirements for Long-term Use

For safe long-term use, the following monitoring is recommended:

  • Baseline assessment: Comprehensive evaluation of renal function, retinal status (especially in diabetics), and cardiovascular risk 6
  • Regular follow-up:
    • Blood pressure monitoring every 3-6 months 2
    • Liver enzyme monitoring at 1,3,6,9, and 12 months, then every 3 months thereafter 2
    • Absolute lymphocyte count monitoring every 3 months 2
    • Regular ophthalmologic evaluation in patients with diabetes or history of retinopathy 2

Duration of Therapy

The FDA has approved Ozempic for long-term use in appropriate patients 2. However:

  • Most clinical trials have followed patients for up to 2-5 years 2, 3
  • There is limited data on continuous use beyond 5 years
  • The American Gastroenterological Association notes that anti-obesity medications generally need to be used chronically for continued effect 2

Special Considerations

Weight Regain Risk

  • Weight regain is common if the medication is discontinued, suggesting the need for continued therapy for sustained weight management 2

Pregnancy Considerations

  • Should be discontinued at least 2 months before planned pregnancy due to the long washout period 6

Off-label Use

  • Increasing use for weight management in patients without diabetes (off-label) 8
  • Semaglutide 2.4mg (higher dose than Ozempic) is FDA-approved specifically for weight management under the brand name Wegovy 2

Conclusion

While Ozempic can be used long-term with appropriate monitoring, patients should be aware of potential side effects and the need for ongoing medical supervision. The decision for lifelong therapy should be based on continued benefit versus risk assessment, with particular attention to cardiovascular outcomes, quality of life improvements, and side effect profile in each individual patient.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.